Table 1.
Cytotoxicity of KO1304 series in A549 cells.
| Sample name | IC30 (μg/mL) | Sample name | IC30 (μg/mL) |
|---|---|---|---|
| KO1304-101 | >100 | KO1304-207 | >100 |
| KO1304-102 | >100 | KO1304-208 | >100 |
| KO1304-103 | >100 | KO1304-221 | >100 |
| KO1304-105 | >100 | KO1304-223 | >100 |
| KO1304-107 | >100 | KO1304-301 | >100 |
| KO1304-201 | >100 | KO1304-302 | >100 |
| KO1304-203 | >100 | KO1304-303 | >100 |
| KO1304-204 | >100 | KO1304-326 | >100 |
| KO1304-205 | >100 | KO1304-328 | 68.3 ± 0.4 |
| KO1304-206 | >100 | KO1304-329 | >100 |
Each extract (titrated from 6.25 to 100 μg/mL) was added to A549 cells for 48 h. IC30 is the concentration at which 30% inhibition of cell viability is achieved.